ArticleJournal of magnetic resonance imaging : JMRI2026
Non-Subtractive Arterial Spin Labeling-Based (NSASL) Renal Magnetic Resonance Angiography (MRA): Development and Clinical Feasibility Evaluation.
Article in Journal of magnetic resonance imaging : JMRI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundNon-contrast renal MR angiography (MRA) is valuable for patients who cannot receive contrast agents or when avoiding radiation is desired. However, the conventional inflow inversion recovery (IFIR) method is limited by incomplete background suppression, venous contamination, and motion sensitivity. PURPOSE: To develop and evaluate a non-subtractive arterial spin labeling-based (NSASL) sequence for renal MRA and compare it with IFIR in healthy volunteers, with exploratory feasibility assessment relative to contrast-enhanced (CE)-MRA or computed tomography angiography (CTA) in patients. STUDY TYPE: Prospective. SUBJECTS: Thirty healthy volunteers (10 male, 35.6 FIELD STRENGTH/SEQUENCE: 1.5 T; 3D stack-of-stars balanced steady-state free precession (bSSFP) NSASL MRA, 3D Cartesian bSSFP IFIR MRA, and CE-MRA. ASSESSMENT: Three radiologists independently rated image quality (main and branch renal arteries visualization, motion artifacts, vessel-to-background contrast, diagnostic confidence) on a 5-point scale. SNR efficiency (or SNR and time) and contrast ratio (CR) were also measured. STATISTICAL TESTS: Intraclass coefficient (ICC), Shapiro-Wilk's test, paired Student's t-test, and Wilcoxon signed-rank test with Bonferroni correction, with p < 0.05 considered statistically significant.
resultsICC was good to excellent (ICC = 0.61-0.89) for average subjective scores. Compared with IFIR, NSASL showed significantly better vessel-to-background contrast (approximately fivefold increase in CR, Cohen's |d| = 2.54; +1 subjective score, |r| = 0.88), improved renal arteries visualization (+0.7 points, |r| = 0.67, corrected p DATA
conclusionNSASL significantly outperformed IFIR, with improved background suppression, vessel conspicuity, motion tolerance, and scan time in healthy volunteers. EVIDENCE LEVEL: 2. TECHNICAL EFFICACY: Stage 2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.